Therapies and Vaccination for Cardiovascular Diseases

Atherosclerosis is that the major cause of acute cardiovascular events such as myocardial infarction and stroke. Current therapies focusing on risk factor reduction, primarily by treatment with sterol lowering statins, have tested to cut back the danger of ischaemic cardiovascular events by up to 400th in randomised clinical trials. Though this has considerably down cardiovascular disease mortality, the majority of patients treated with medicine medical aid are still without effective CVD protection. Through experimental, clinical and medical specialty research, therefore, targeting the inflammatory disease method within the coronary-artery disease plaque represents an exciting new frontier for medical aid development.


  • antigen-specific Treg cells
  • Immune tolerance to atherosclerotic antigens
  • Anti-CD3 antibodies
  • Anti-CD3 antibodies
  • IL-2 and IL-2/anti-IL-2 immune complex
  • Vitamin D3
  • Tolerogenic vaccines

Related Conference of Therapies and Vaccination for Cardiovascular Diseases

January 31- February 01, 2019

18th International Conference on Obesity Diet & Nutrition

Paris | France
June 06-07, 2018

International Congress on Obesity & Nutrition

Philadelphuia, Pennsylvania USA
March 15-16, 2019

International Conference on Bariatric and Metabolic Surgery

Novotel Brisbane, Brisbane, Australia
March 25-26, 2019

2nd World Obesity and Healthcare Congress

Rotterdam, Netherlands
June 21-22, 2019

21st Global Obesity Meeting

Brisbane, Australia

Therapies and Vaccination for Cardiovascular Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in